| UniProt ID | PSMG1_HUMAN | |
|---|---|---|
| UniProt AC | O95456 | |
| Protein Name | Proteasome assembly chaperone 1 | |
| Gene Name | PSMG1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 288 | |
| Subcellular Localization | Cytoplasm. Endoplasmic reticulum. | |
| Protein Description | Chaperone protein which promotes assembly of the 20S proteasome as part of a heterodimer with PSMG2. The PSMG1-PSMG2 heterodimer binds to the PSMA5 and PSMA7 proteasome subunits, promotes assembly of the proteasome alpha subunits into the heteroheptameric alpha ring and prevents alpha ring dimerization.. | |
| Protein Sequence | MAATFFGEVVKAPCRAGTEDEEEEEEGRRETPEDREVRLQLARKREVRLLRRQTKTSLEVSLLEKYPCSKFIIAIGNNAVAFLSSFVMNSGVWEEVGCAKLWNEWCRTTDTTHLSSTEAFCVFYHLKSNPSVFLCQCSCYVAEDQQYQWLEKVFGSCPRKNMQITILTCRHVTDYKTSESTGSLPSPFLRALKTQNFKDSACCPLLEQPNIVHDLPAAVLSYCQVWKIPAILYLCYTDVMKLDLITVEAFKPILSTRSLKGLVKNIPQSTEILKKLMTTNEIQSNIYT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAATFFGEV ------CCCCCCCCC | 18.40 | 22223895 | |
| 4 | Phosphorylation | ----MAATFFGEVVK ----CCCCCCCCCCC | 15.23 | 20068231 | |
| 11 | Ubiquitination | TFFGEVVKAPCRAGT CCCCCCCCCCCCCCC | 52.35 | 24816145 | |
| 11 | Acetylation | TFFGEVVKAPCRAGT CCCCCCCCCCCCCCC | 52.35 | 27452117 | |
| 15 | Methylation | EVVKAPCRAGTEDEE CCCCCCCCCCCCCHH | 34.69 | - | |
| 18 | Phosphorylation | KAPCRAGTEDEEEEE CCCCCCCCCCHHHHH | 39.00 | 23401153 | |
| 31 | Phosphorylation | EEEGRRETPEDREVR HHHHCCCCHHHHHHH | 30.11 | 25159151 | |
| 35 | Methylation | RRETPEDREVRLQLA CCCCHHHHHHHHHHH | 42.52 | - | |
| 54 | Phosphorylation | VRLLRRQTKTSLEVS HHHHHHHCCCCCHHH | 34.18 | 23911959 | |
| 55 | Ubiquitination | RLLRRQTKTSLEVSL HHHHHHCCCCCHHHH | 27.98 | 29967540 | |
| 56 | Phosphorylation | LLRRQTKTSLEVSLL HHHHHCCCCCHHHHH | 41.76 | 29978859 | |
| 57 | Phosphorylation | LRRQTKTSLEVSLLE HHHHCCCCCHHHHHH | 24.88 | 26074081 | |
| 61 | Phosphorylation | TKTSLEVSLLEKYPC CCCCCHHHHHHHCCC | 20.19 | 24719451 | |
| 65 | Acetylation | LEVSLLEKYPCSKFI CHHHHHHHCCCCCEE | 55.23 | 25038526 | |
| 65 | Ubiquitination | LEVSLLEKYPCSKFI CHHHHHHHCCCCCEE | 55.23 | 32015554 | |
| 68 | Ubiquitination | SLLEKYPCSKFIIAI HHHHHCCCCCEEEEE | 6.66 | 21963094 | |
| 85 | Ubiquitination | NAVAFLSSFVMNSGV CHHHHHHHHHHCCCC | 24.81 | 22817900 | |
| 89 | Ubiquitination | FLSSFVMNSGVWEEV HHHHHHHCCCCHHCH | 30.25 | 21963094 | |
| 90 | Ubiquitination | LSSFVMNSGVWEEVG HHHHHHCCCCHHCHH | 19.34 | 21963094 | |
| 106 | Ubiquitination | AKLWNEWCRTTDTTH HHHHHHHHCCCCCCC | 1.95 | 22817900 | |
| 111 | Ubiquitination | EWCRTTDTTHLSSTE HHHCCCCCCCCCCCC | 17.64 | 21963094 | |
| 135 (in isoform 2) | Phosphorylation | - | 2.32 | - | |
| 143 | Ubiquitination | QCSCYVAEDQQYQWL EEEEEEECHHHHHHH | 46.43 | 21890473 | |
| 152 | Ubiquitination | QQYQWLEKVFGSCPR HHHHHHHHHHCCCCC | 40.47 | 23000965 | |
| 155 | Ubiquitination | QWLEKVFGSCPRKNM HHHHHHHCCCCCCCC | 31.18 | 21963094 | |
| 155 (in isoform 2) | Ubiquitination | - | 31.18 | 21890473 | |
| 156 | Ubiquitination | WLEKVFGSCPRKNMQ HHHHHHCCCCCCCCE | 14.96 | 21890473 | |
| 160 | Ubiquitination | VFGSCPRKNMQITIL HHCCCCCCCCEEEEE | 41.75 | - | |
| 164 | Ubiquitination | CPRKNMQITILTCRH CCCCCCEEEEEEEEE | 1.47 | 21890473 | |
| 166 | Ubiquitination | RKNMQITILTCRHVT CCCCEEEEEEEEEEC | 2.99 | 22817900 | |
| 167 | Ubiquitination | KNMQITILTCRHVTD CCCEEEEEEEEEECC | 2.50 | 21963094 | |
| 171 | Ubiquitination | ITILTCRHVTDYKTS EEEEEEEEECCCCCC | 29.04 | 21963094 | |
| 172 | Ubiquitination | TILTCRHVTDYKTSE EEEEEEEECCCCCCC | 1.94 | 22817900 | |
| 172 (in isoform 2) | Ubiquitination | - | 1.94 | 21890473 | |
| 173 | Ubiquitination | ILTCRHVTDYKTSES EEEEEEECCCCCCCC | 27.73 | 23000965 | |
| 176 (in isoform 1) | Ubiquitination | - | 48.67 | 21890473 | |
| 176 | Ubiquitination | CRHVTDYKTSESTGS EEEECCCCCCCCCCC | 48.67 | 21906983 | |
| 177 | Ubiquitination | RHVTDYKTSESTGSL EEECCCCCCCCCCCC | 31.34 | 23000965 | |
| 177 | Phosphorylation | RHVTDYKTSESTGSL EEECCCCCCCCCCCC | 31.34 | 23312004 | |
| 178 | Phosphorylation | HVTDYKTSESTGSLP EECCCCCCCCCCCCC | 25.95 | 23312004 | |
| 180 | Phosphorylation | TDYKTSESTGSLPSP CCCCCCCCCCCCCHH | 37.52 | 23917254 | |
| 181 | Phosphorylation | DYKTSESTGSLPSPF CCCCCCCCCCCCHHH | 27.09 | 23917254 | |
| 183 | Phosphorylation | KTSESTGSLPSPFLR CCCCCCCCCCHHHHH | 36.88 | 28985074 | |
| 186 | Phosphorylation | ESTGSLPSPFLRALK CCCCCCCHHHHHHHH | 33.31 | 23186163 | |
| 187 | Ubiquitination | STGSLPSPFLRALKT CCCCCCHHHHHHHHH | 30.28 | 27667366 | |
| 188 | Ubiquitination | TGSLPSPFLRALKTQ CCCCCHHHHHHHHHC | 9.40 | 21963094 | |
| 193 | Ubiquitination | SPFLRALKTQNFKDS HHHHHHHHHCCCCCC | 47.26 | 21906983 | |
| 193 (in isoform 1) | Ubiquitination | - | 47.26 | 21890473 | |
| 193 | Methylation | SPFLRALKTQNFKDS HHHHHHHHHCCCCCC | 47.26 | - | |
| 198 | Ubiquitination | ALKTQNFKDSACCPL HHHHCCCCCCCCCHH | 59.32 | 21963094 | |
| 230 | Ubiquitination | CQVWKIPAILYLCYT HHHHCCCHHHHHHHC | 14.11 | 21890473 | |
| 230 (in isoform 2) | Ubiquitination | - | 14.11 | 21890473 | |
| 239 | Ubiquitination | LYLCYTDVMKLDLIT HHHHHCCCHHCCEEE | 2.55 | 23000965 | |
| 243 | Ubiquitination | YTDVMKLDLITVEAF HCCCHHCCEEEHHHH | 30.43 | 23000965 | |
| 243 | Acetylation | YTDVMKLDLITVEAF HCCCHHCCEEEHHHH | 30.43 | 19608861 | |
| 243 (in isoform 2) | Ubiquitination | - | 30.43 | 21890473 | |
| 246 | Ubiquitination | VMKLDLITVEAFKPI CHHCCEEEHHHHHHH | 21.42 | 21890473 | |
| 251 | Ubiquitination | LITVEAFKPILSTRS EEEHHHHHHHHCCCC | 37.89 | 21963094 | |
| 251 | Acetylation | LITVEAFKPILSTRS EEEHHHHHHHHCCCC | 37.89 | 23954790 | |
| 251 (in isoform 1) | Ubiquitination | - | 37.89 | 21890473 | |
| 253 | Ubiquitination | TVEAFKPILSTRSLK EHHHHHHHHCCCCHH | 4.97 | 27667366 | |
| 254 | Ubiquitination | VEAFKPILSTRSLKG HHHHHHHHCCCCHHH | 6.08 | 21963094 | |
| 254 (in isoform 2) | Ubiquitination | - | 6.08 | 21890473 | |
| 255 | Phosphorylation | EAFKPILSTRSLKGL HHHHHHHCCCCHHHH | 23.61 | 24719451 | |
| 255 | Ubiquitination | EAFKPILSTRSLKGL HHHHHHHCCCCHHHH | 23.61 | 23000965 | |
| 256 | O-linked_Glycosylation | AFKPILSTRSLKGLV HHHHHHCCCCHHHHH | 22.34 | 30059200 | |
| 259 | Ubiquitination | PILSTRSLKGLVKNI HHHCCCCHHHHHHCC | 4.61 | 23000965 | |
| 260 | Acetylation | ILSTRSLKGLVKNIP HHCCCCHHHHHHCCC | 51.98 | 25953088 | |
| 260 | Ubiquitination | ILSTRSLKGLVKNIP HHCCCCHHHHHHCCC | 51.98 | 23000965 | |
| 264 | Malonylation | RSLKGLVKNIPQSTE CCHHHHHHCCCCHHH | 54.95 | 26320211 | |
| 264 | Acetylation | RSLKGLVKNIPQSTE CCHHHHHHCCCCHHH | 54.95 | 19608861 | |
| 264 | Ubiquitination | RSLKGLVKNIPQSTE CCHHHHHHCCCCHHH | 54.95 | 23000965 | |
| 264 (in isoform 1) | Ubiquitination | - | 54.95 | 21890473 | |
| 269 | Ubiquitination | LVKNIPQSTEILKKL HHHCCCCHHHHHHHH | 23.74 | 27667366 | |
| 270 | Ubiquitination | VKNIPQSTEILKKLM HHCCCCHHHHHHHHH | 23.07 | 21963094 | |
| 274 | Ubiquitination | PQSTEILKKLMTTNE CCHHHHHHHHHCHHH | 49.90 | 27667366 | |
| 275 | Ubiquitination | QSTEILKKLMTTNEI CHHHHHHHHHCHHHH | 39.79 | 21963094 | |
| 275 (in isoform 1) | Ubiquitination | - | 39.79 | 21890473 | |
| 287 | Phosphorylation | NEIQSNIYT------ HHHHHHCCC------ | 15.62 | 27642862 | |
| 288 | Phosphorylation | EIQSNIYT------- HHHHHCCC------- | 28.47 | 29978859 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PSMG1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PSMG1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PSMG1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PPARD_HUMAN | PPARD | physical | 18793612 | |
| PSMG2_HUMAN | PSMG2 | physical | 22939629 | |
| APEX1_HUMAN | APEX1 | physical | 22863883 | |
| CAZA1_HUMAN | CAPZA1 | physical | 22863883 | |
| CAZA2_HUMAN | CAPZA2 | physical | 22863883 | |
| EHD4_HUMAN | EHD4 | physical | 22863883 | |
| NOL3_HUMAN | NOL3 | physical | 22863883 | |
| SC23A_HUMAN | SEC23A | physical | 22863883 | |
| PSMG3_HUMAN | PSMG3 | physical | 17189198 | |
| PSMG1_HUMAN | PSMG1 | physical | 17189198 | |
| PSMG2_HUMAN | PSMG2 | physical | 17189198 | |
| PSA7_HUMAN | PSMA7 | physical | 17189198 | |
| PSA6_HUMAN | PSMA6 | physical | 17189198 | |
| PSA5_HUMAN | PSMA5 | physical | 17189198 | |
| PSA2_HUMAN | PSMA2 | physical | 17189198 | |
| POMP_HUMAN | POMP | physical | 17189198 | |
| PSMG2_HUMAN | PSMG2 | physical | 26109405 | |
| RHDF1_HUMAN | RHBDF1 | physical | 26109405 | |
| POMP_HUMAN | POMP | physical | 27173435 | |
| CE120_HUMAN | CEP120 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-264, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-56 AND SER-57, AND MASSSPECTROMETRY. | |